We are live on ! Find out more
Flagship Pioneering

Flagship Pioneering Portfolio holdings

AUM $1.54B Turnover 0%
1-Year Est. Return 86.39%
This Fund
S&P 500
This Quarter Est. Return
+33.2%
1 Year Est. Return
+86.39%
3 Year Est. Return
-13.28%
5 Year Est. Return
-50.7%
10 Year Est. Return
+414.55%
AUM
$1.54B
AUM Growth
+$378M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
5.7 years
Top 10 Avg Time Held
5.7 years
Top 20 Avg Time Held
5.7 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GENB icon
1
Generate Biomedicines
GENB
$1.68B
$1.06B 68.66%
62,673,117
– –
2026 Q1
1 quarter
MRNA icon
2
Moderna
MRNA
$98.1B
$324M 21.07%
4,632,149
– –
2018 Q4
30 quarters
SANA icon
3
Sana Biotechnology
SANA
$703M
$87.3M 5.67%
25,001,856
– –
2021 Q1
21 quarters
FHTX icon
4
Foghorn Therapeutics
FHTX
$121M
$61.8M 4.02%
12,674,120
– –
2020 Q4
22 quarters
MCRB icon
5
Seres Therapeutics
MCRB
$23.1M
$9.12M 0.59%
1,155,850
– –
2016 Q3
39 quarters

Similar funds

SPC
Stony Point Capital New York $1.54B AUM 54.05% 1-Year Est. Return
Abundance Wealth Counselors
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return
Smith, Moore & Co
Smith, Moore & Co Clayton, Missouri $1.54B AUM 24.82% 1-Year Est. Return
Landscape Capital Management
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
Cumberland Partners
Cumberland Partners Toronto, Ontario, Canada $1.54B AUM 27.61% 1-Year Est. Return
Hollencrest Capital Management
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
Bouchey Financial Group
Bouchey Financial Group Troy, New York $1.55B AUM 29.02% 1-Year Est. Return
Callodine Capital Management
Callodine Capital Management Boston, Massachusetts $1.53B AUM 18.8% 1-Year Est. Return

Flagship Pioneering's Q2 2026 Portfolio in Review

As of Q2 2026, Flagship Pioneering held 5 positions worth $1.54B, up 33% from $1.16B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Flagship Pioneering opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's ten largest holdings make up 100% of its $1.54B portfolio in Q2 2026.
  • Flagship Pioneering opened 0 new positions and closed 0 in Q2 2026.
  • Flagship Pioneering's portfolio value rose 33% quarter-over-quarter to $1.54B.

Based on Flagship Pioneering's 13F filing for Q2 2026, filed 14 Aug 2026.